SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
A securities class action traces ARS Pharmaceuticals' alleged March-to-June 2026 disclosure sequence on CVS Caremark coverage for neffy, ending in a one-day 23.9% collapse in SPRY shares. NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of ARS...
Covered in this story
What has happened since
- Ars Pharmaceuticals Inc is down 25.8% since this was published, 50 days ago.
- CVS Health is down 2.8% since this was published, 50 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SPRY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Ars Pharmaceuticals Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.